Blood Lancet Latest Market Report 2026

On Jan 28, Global Info Research released "Global Blood Lancet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report includes an overview of the development of the Blood Lancet industry chain, the market status of Blood Lancet Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Blood Lancet.

According to our (Global Info Research) latest study, the global Blood Lancet market size was valued at US$ 1722 million in 2024 and is forecast to a readjusted size of USD 2107 million by 2031 with a CAGR of 2.9% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Blood lancets are medical devices designed to puncture the skin to obtain capillary blood samples, widely used in blood glucose monitoring, hematology testing, infectious disease screening, and newborn metabolic disorder screening. They typically consist of a needle, needle housing, protective cap, and automated lancing mechanism, emphasizing minimally invasive, painless, and single-use features to minimize cross-contamination risks. Driven by chronic disease management and personalized healthcare, blood lancet products are evolving from traditional manual types to safety-engineered, automated, and microneedle designs, balancing usability and patient comfort. With stringent adherence to ISO, FDA, and national medical device standards, leading manufacturers are advancing intelligent production and cost optimization to meet rising global demand.In 2024, global Blood Lancet production reached approximately 55.37 billion units, with an average global market price of around 30.22 US$/k unit.
The global blood lancet market is driven by the rising prevalence of chronic diseases and growing demand for home self-testing, particularly among patients with diabetes and hypertension, which fuels steady growth in blood glucose monitoring consumables. According to WHO and national public health authorities, there are over 500 million diabetes patients worldwide, making blood glucose monitoring a critical part of daily healthcare. Government initiatives promoting primary care and early screening systems are further expanding market potential. Advances in intelligent manufacturing, automated production, and high-precision molding technologies have significantly improved product safety, consistency, and comfort, accelerating the industry shift from low-cost competition to branded and premium segments. Global leaders and Chinese manufacturers are forming a complementary supply chain ecosystem, with expanding opportunities in cross-border market development and OEM/ODM partnerships that attract capital and innovation.Despite robust demand, the market faces multiple challenges. Regulatory compliance is becoming increasingly stringent, with manufacturers required to invest heavily to meet FDA, CE, and ISO certifications, increasing operational costs. The highly fragmented competitive landscape and intense price competition, especially in the low-end market, continue to erode profit margins, making technology innovation and economies of scale key to success. Additionally, raw material price volatility and global supply chain uncertainties have intensified cost pressures, particularly after 2020, when logistics expenses and raw material costs surged. Environmental regulations are also tightening, placing additional requirements on needle manufacturing, plastic material usage, and waste disposal, posing long-term compliance risks for manufacturers.Applications for blood lancets are expanding from traditional hospital and laboratory testing to home use, community clinics, and mobile healthcare, with increasing demand for personalized and user-friendly products. The need for continuous monitoring among chronic disease patients is driving rapid growth in automated, retractable, adjustable-depth, and minimally invasive lancet designs. Newborn screening, public health testing programs, health checkup centers, and retail pharmacy channels are further enlarging market capacity. Moreover, the ongoing digitalization of healthcare systems positions blood lancets as an essential entry point for in vitro diagnostics, integrating with wearable devices, remote monitoring platforms, and cloud-based data systems. This shift is propelling manufacturers toward becoming integrated healthcare solution providers, unlocking long-term growth potential for the industry.
This report is a detailed and comprehensive analysis for global Blood Lancet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Sample Report Request Blood Lancet
https://www.globalinforesearch.com/reports/2897477/blood-lancet

Market segment by Type: Conventional Lancets、 Safety Lancets
Market segment by Application: Hospital、 Clinic、 Others
Major players covered:  Roche、 Lifescan、 BD、 MTD 集团、 Greiner Bio One、 Owen Mumford、 Cardinal Health、 Ascensia、 Abbott、 B. Braun、 Terumo、 I-SENS、 Nipro、 ICU Medical、 Sarstedt、 Sinocare、 Yueyue Medical、 Tianjin Huahong Medical、 Suzhou Shilai Medical、 Shandong Lianfa Medical、 Promisemed
Market segment by region, regional analysis covers:
North America (United States, Canada and Mexico),
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),
South America (Brazil, Argentina, Colombia, and Rest of South America),
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Lancet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Lancet, with price, sales, revenue and global market share of Blood Lancet from 2021 to 2025.
Chapter 3, the Blood Lancet competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Lancet breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2021 to 2025.and Blood Lancet market forecast, by regions, type and application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Lancet.
Chapter 14 and 15, to describe Blood Lancet sales channel, distributors, customers, research findings and conclusion.

Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.

From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.

About Us:

Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com

Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.